Johnson & Johnson (JNJ) — Technical state
As of 2026-10-12 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
Trades -0.6% vs the 50-day and +8.6% vs the 200-day average, 6.2% below the 52-week high and +44.5% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day-0.3%
- vs 50-day-0.6%
- vs 200-day+8.6%
- 52-week band6.2% off the high · +44.5% off the low
- Streak2 consecutive up sessions
- 50-day crossprice crossed down through the 50-day 8 sessions ago
- Stochastic%K 52.2 · %D 31.7
Continue: the JNJ chart & overview · the earnings record · the signal board
FAQ · from the current data · as of 2026-10-12
Quick answers
What is the current Closelooknet signal on JNJ?
Pullback inside an uptrend stack — Trades -0.6% vs the 50-day and +8.6% vs the 200-day average, 6.2% below the 52-week high and +44.5% off the 52-week low. Computed from daily closes. As of 2026-10-12; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is JNJ above its 50-day and 200-day moving averages?
As of 2026-10-12, Johnson & Johnson trades -0.6% below its 50-day and +8.6% above its 200-day average, with the 20-day -0.3% away.
How far is JNJ from its 52-week high?
6.2% below the 52-week high and 44.5% above the 52-week low, as of 2026-10-12.
Mentioned on Closelooknet
Where JNJ appears in the diary — 9 pieces, newest first. Every link is our own writing.
Go deeper
Long reads
- Covered Calls for Income — the Dividend Aristocrats Approach
The list overlaps heavily with the consumer-staples / industrials / healthcare slow-compounders: KO, PG, JNJ, KMB, MMM, ED, ABT, MMC, EMR, ITW, and on.
Dailies
- Earnings — J&J −6.2% and Citi −3.8% after beats; Micron −5.1%, chip fund back under its 50-day line
Johnson & Johnson is down 6.2% after topping estimates and raising its outlook; Citigroup is down 3.8% after a beat on both lines.
- Temperature 59 — Rubin surges 25% monthly as cointegration breaks pile up
The top five hits are all support-confluence reads — NOC, MCD, PFE, JNJ, and MA — with the two highest-confidence names, NOC and MCD, carrying red-regime labels.
- Temperature 59 — first crack in semis, defensives bid
The Pattern Scanner registered 28 active signals, top five clustered in support-confluence setups: NOC at 41 confidence and MCD at 37, both in red regimes, alongside PFE and JNJ in yellow.
- Temperature 61 — semis overheating into the catalyst window
The Pattern Scanner registered 26 active signals, with the top five concentrated in support-confluence setups across pharma, defense, and consumer staples — AZN and JNJ lead at 44 and 43 confidence respectively, both in yellow-regime.
- Temperature 62 — Euro-AI leads broad multi-week rally
AZN, JNJ and NOW are flagged in yellow or green regimes — defensives and high-quality software finding floors.
- Temperature 57 — Rubin surges 2.3%, seven cointegration breaks widen
The top hits — AZN, NOC, JNJ, MCD, LMT — are defensive and industrial names carrying yellow or red regime labels.
- Temperature 56 — Rubin surges 3.4%, defensive clusters form
The Pattern Scanner registered 27 active signals, with the top five hits concentrated in support-confluence setups across defensively oriented names: JNJ, AZN, MCD, NOC, and SAP.
- Temperature 58 — Rubin surges 30% monthly as cointegration breaks pile up
The Pattern Scanner returned 32 active signals, with the top cluster concentrated in support-confluence setups across defensive and consumer names — NOC, JNJ, UL, MCD, and XOM.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- GSK GlaxoSmithKline PLC ADRindustry
- ABBV AbbVie Incindustry
- BIIB Biogen Incindustry
- GILD Gilead Sciences Incindustry
- PFE Pfizer Incindustry
- MRK Merck & Company Incindustry
- AMGN Amgen Incindustry
- OGN Organon & Coindustry
- SNY Sanofi ADRindustry
- BMY Bristol-Myers Squibb Companyindustry
- AZN AstraZeneca PLCindustry
- HALO Halozyme Therapeutics Incsector
- DXCM DexCom Incsector
- ONC BeiGene, Ltd.sector
- MEDP Medpace Holdings Incsector